Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research - Lafayette, Louisiana

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity Clinical Research – Lafayette is a clinical trial research site located in Lafayette, Louisiana, and is part of the global Velocity Clinical Research network. Velocity Clinical Research is an integrated site organization that collaborates with pharmaceutical, biotechnology, and medical device companies to conduct clinical trials that support the development of new therapies and medical innovations. The Lafayette site conducts Phase II–IV clinical studies across multiple therapeutic areas, including internal medicine, cardiology, endocrinology, vaccines, and infectious diseases. The facility works closely with experienced physician investigators and trained research coordinators to ensure high-quality clinical research while maintaining strict compliance with regulatory and ethical guidelines. The center is equipped with modern clinical research infrastructure including patient examination rooms, laboratory support, investigational product storage, and data management…

Source: Trial-derived.
45Total Trials
Source: Trial-derived.
7Recruiting Trials
Source: Trial-derived.
19Active Trials
Source: Trial-derived.
23Completed Trials
Source: Trial-derived.
48Unique Conditions
Source: Trial-derived.
39Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. COVID-19 (4)Source: Trial-derived. Asthma (3)Source: Trial-derived. Dermatitis Atopic (3)Source: Trial-derived. Obesity (3)Source: Trial-derived. Respiratory Syncytial Virus (3)Source: Trial-derived. Influenza, Human (2)Source: Trial-derived. Overweight (2)Source: Trial-derived. SARS-CoV-2 (2)

Sponsors

Source: Trial-derived. ModernaTX, Inc. (7)Source: Trial-derived. Sanofi (5)Source: Trial-derived. AbbVie (2)Source: Trial-derived. Eli Lilly and Company (2)Source: Trial-derived. IQVIA Pty Ltd (2)Source: Trial-derived. Ironwood Pharmaceuticals, Inc. (2)Source: Trial-derived. Novavax (2)Source: Trial-derived. Novo Nordisk A/S (2)

Trial Phases

Historical Trial Phase Experience

Source: Human-provided. Phase II
Source: Human-provided. Phase III

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Electronic source (eSource) system

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Continuous glucose monitoring
Source: AI-inferred. Spirometry

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. PBMC isolation & cryopreservation
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Blood glucose meter monitoring
Source: AI-inferred. ELISpot assay
Source: AI-inferred. Fractional exhaled nitric oxide (FeNO) measurement
Source: AI-inferred. Hemagglutination inhibition (HAI) assay
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay
Source: AI-inferred. Interferon-gamma release assay (IGRA) tuberculosis testing
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. Ophthalmological retinopathy examination